TwinBeech Capital’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
TwinBeech Capital's IONS Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 4,795 shares worth $214K. The stake represents 0.05% of the portfolio and ranks #350 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in IONS as recently as Q1 2025.
TwinBeech Capital first reported a position in IONS in Q3 2020 and has held it in 8 quarters since. The position peaked at $9.43M in Q3 2024. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- TwinBeech Capital held 4,795 shares of Ionis Pharmaceuticals worth $214K as of Q3 2026.
- Ionis Pharmaceuticals was a new TwinBeech Capital position in Q3 2026.
- Ionis Pharmaceuticals made up 0.05% of TwinBeech Capital's portfolio in Q3 2026, its #350 holding.
- TwinBeech Capital first reported a position in Ionis Pharmaceuticals in Q3 2020 and has held it in 8 quarters since.
- TwinBeech Capital's Ionis Pharmaceuticals position peaked at $9.43M in Q3 2024.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.